Estimating neural activity from visual areas using functionally defined EEG templates

This work was supported by BBSRC grant BB/N018516/1 and Wellcome Trust ISSF 204821/Z/16/Z.Electroencephalography (EEG) is a common and inexpensive method to record neural activity in humans. However, it lacks spatial resolution making it difficult to determine which areas of the brain are responsible for the observed EEG response. Here we present a new easy-to-use method that relies on EEG topographical templates. Using MRI and fMRI scans of 50 participants, we simulated how the activity in each visual area appears on the scalp and averaged this signal to produce functionally defined EEG templates. Once created, these templates can be used to estimate how much each visual area contributes to the observed EEG activity. We tested this method on extensive simulations and on real data. The proposed procedure is as good as bespoke individual source localization methods, robust to a wide range of factors, and has several strengths. First, because it does not rely on individual brain scans, it is inexpensive and can be used on any EEG data set, past or present. Second, the results are readily interpretable in terms of functional brain regions and can be compared across neuroimaging techniques. Finally, this method is easy to understand, simple to use and expandable to other brain sources.Publisher PDFPeer reviewe

Assessing direction-specific adaptation using the steady-state visual evoked potential: Results from EEG source imaging

Studying directional selectivity using neuroimaging in humans is difficult because the resolution is insufficient to directly access directionally selective activity. Here we used motion adaptation of the steady-state visual evoked potential (SSVEP) and source imaging in the frequency domain to detect brain areas that contain direction-selective cells. This study uses a definitive electrophysiological marker for direction-specific adaptation in the SSVEP to localize cortical areas that are direction selective. It has been shown previously that an oscillating stimulus produces an SSVEP response that is dominated by even harmonics of the stimulus frequency. This pattern of response is consistent with equal population responses to each direction of motion. Prolonged exposure to unidirectional motion induces an asymmetry in the population response that is consistent with adaptation of direction-selective cells. This asymmetry manifests itself in the presence of odd harmonic components after adaptation Critically, the feature that indicates the direction used for adaptation is the phase of the odd-harmonic responses. We recorded this signature of direction selectivity in a group of observers whose retinotopic visual areas had been defined from fMRI mapping. We find direction-specific responses throughout retinotopic cortex, with the largest effect in areas V1 (occipital pole) and V3/V3a (dorsal)

Speed change discrimination for motion in depth using constant world and retinal speeds

This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC; https://bbsrc.ukri.org/) [grant number BB/M010996/1 to ARIL, BB/N018516/1 to JMA and BB/M001660/1 to JMH].Motion at constant speed in the world maps into retinal motion very differently for lateral motion and motion in depth. The former is close to linear, for the latter, constant speed objects accelerate on the retina as they approach. Motion in depth is frequently studied using speeds that are constant on the retina, and are thus not consistent with real-world constant motion. Our aim here was to test whether this matters: are we more sensitive to real-world motion? We measured speed change discrimination for objects undergoing accelerating retinal motion in depth (consistent with constant real-world speed), and constant retinal motion in depth (consistent with real-world deceleration). Our stimuli contained both looming and binocular disparity cues to motion in depth. We used a speed change discrimination task to obtain thresholds for conditions with and without binocular and looming motion in depth cues. We found that speed change discrimination thresholds were similar for accelerating retinal speed and constant retinal speed and were notably poor compared to classic speed discrimination thresholds. We conclude that the ecologically valid retinal acceleration in our stimuli neither helps, nor hinders, our ability to make judgements in a speed change discrimination task.Publisher PDFPeer reviewe

The Time Course of Segmentation and Cue-Selectivity in the Human Visual Cortex

Texture discontinuities are a fundamental cue by which the visual system segments objects from their background. The neural mechanisms supporting texture-based segmentation are therefore critical to visual perception and cognition. In the present experiment we employ an EEG source-imaging approach in order to study the time course of texture-based segmentation in the human brain. Visual Evoked Potentials were recorded to four types of stimuli in which periodic temporal modulation of a central 3° figure region could either support figure-ground segmentation, or have identical local texture modulations but not produce changes in global image segmentation. The image discontinuities were defined either by orientation or phase differences across image regions. Evoked responses to these four stimuli were analyzed both at the scalp and on the cortical surface in retinotopic and functional regions-of-interest (ROIs) defined separately using fMRI on a subject-by-subject basis. Texture segmentation (tsVEP: segmenting versus non-segmenting) and cue-specific (csVEP: orientation versus phase) responses exhibited distinctive patterns of activity. Alternations between uniform and segmented images produced highly asymmetric responses that were larger after transitions from the uniform to the segmented state. Texture modulations that signaled the appearance of a figure evoked a pattern of increased activity starting at ∼143 ms that was larger in V1 and LOC ROIs, relative to identical modulations that didn't signal figure-ground segmentation. This segmentation-related activity occurred after an initial response phase that did not depend on the global segmentation structure of the image. The two cue types evoked similar tsVEPs up to 230 ms when they differed in the V4 and LOC ROIs. The evolution of the response proceeded largely in the feed-forward direction, with only weak evidence for feedback-related activity

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Background: Detailed, comprehensive, and timely reporting on population health by underlying causes of disability and premature death is crucial to understanding and responding to complex patterns of disease and injury burden over time and across age groups, sexes, and locations. The availability of disease burden estimates can promote evidence-based interventions that enable public health researchers, policy makers, and other professionals to implement strategies that can mitigate diseases. It can also facilitate more rigorous monitoring of progress towards national and international health targets, such as the Sustainable Development Goals. For three decades, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) has filled that need. A global network of collaborators contributed to the production of GBD 2021 by providing, reviewing, and analysing all available data. GBD estimates are updated routinely with additional data and refined analytical methods. GBD 2021 presents, for the first time, estimates of health loss due to the COVID-19 pandemic. Methods: The GBD 2021 disease and injury burden analysis estimated years lived with disability (YLDs), years of life lost (YLLs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries using 100 983 data sources. Data were extracted from vital registration systems, verbal autopsies, censuses, household surveys, disease-specific registries, health service contact data, and other sources. YLDs were calculated by multiplying cause-age-sex-location-year-specific prevalence of sequelae by their respective disability weights, for each disease and injury. YLLs were calculated by multiplying cause-age-sex-location-year-specific deaths by the standard life expectancy at the age that death occurred. DALYs were calculated by summing YLDs and YLLs. HALE estimates were produced using YLDs per capita and age-specific mortality rates by location, age, sex, year, and cause. 95% uncertainty intervals (UIs) were generated for all final estimates as the 2·5th and 97·5th percentiles values of 500 draws. Uncertainty was propagated at each step of the estimation process. Counts and age-standardised rates were calculated globally, for seven super-regions, 21 regions, 204 countries and territories (including 21 countries with subnational locations), and 811 subnational locations, from 1990 to 2021. Here we report data for 2010 to 2021 to highlight trends in disease burden over the past decade and through the first 2 years of the COVID-19 pandemic. Findings: Global DALYs increased from 2·63 billion (95% UI 2·44–2·85) in 2010 to 2·88 billion (2·64–3·15) in 2021 for all causes combined. Much of this increase in the number of DALYs was due to population growth and ageing, as indicated by a decrease in global age-standardised all-cause DALY rates of 14·2% (95% UI 10·7–17·3) between 2010 and 2019. Notably, however, this decrease in rates reversed during the first 2 years of the COVID-19 pandemic, with increases in global age-standardised all-cause DALY rates since 2019 of 4·1% (1·8–6·3) in 2020 and 7·2% (4·7–10·0) in 2021. In 2021, COVID-19 was the leading cause of DALYs globally (212·0 million [198·0–234·5] DALYs), followed by ischaemic heart disease (188·3 million [176·7–198·3]), neonatal disorders (186·3 million [162·3–214·9]), and stroke (160·4 million [148·0–171·7]). However, notable health gains were seen among other leading communicable, maternal, neonatal, and nutritional (CMNN) diseases. Globally between 2010 and 2021, the age-standardised DALY rates for HIV/AIDS decreased by 47·8% (43·3–51·7) and for diarrhoeal diseases decreased by 47·0% (39·9–52·9). Non-communicable diseases contributed 1·73 billion (95% UI 1·54–1·94) DALYs in 2021, with a decrease in age-standardised DALY rates since 2010 of 6·4% (95% UI 3·5–9·5). Between 2010 and 2021, among the 25 leading Level 3 causes, age-standardised DALY rates increased most substantially for anxiety disorders (16·7% [14·0–19·8]), depressive disorders (16·4% [11·9–21·3]), and diabetes (14·0% [10·0–17·4]). Age-standardised DALY rates due to injuries decreased globally by 24·0% (20·7–27·2) between 2010 and 2021, although improvements were not uniform across locations, ages, and sexes. Globally, HALE at birth improved slightly, from 61·3 years (58·6–63·6) in 2010 to 62·2 years (59·4–64·7) in 2021. However, despite this overall increase, HALE decreased by 2·2% (1·6–2·9) between 2019 and 2021. Interpretation: Putting the COVID-19 pandemic in the context of a mutually exclusive and collectively exhaustive list of causes of health loss is crucial to understanding its impact and ensuring that health funding and policy address needs at both local and global levels through cost-effective and evidence-based interventions. A global epidemiological transition remains underway. Our findings suggest that prioritising non-communicable disease prevention and treatment policies, as well as strengthening health systems, continues to be crucially important. The progress on reducing the burden of CMNN diseases must not stall; although global trends are improving, the burden of CMNN diseases remains unacceptably high. Evidence-based interventions will help save the lives of young children and mothers and improve the overall health and economic conditions of societies across the world. Governments and multilateral organisations should prioritise pandemic preparedness planning alongside efforts to reduce the burden of diseases and injuries that will strain resources in the coming decades. Funding: Bill & Melinda Gates Foundation

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation

Estimating neural activity from visual areas using functionally defined EEG templates

Electroencephalography (EEG) is a common and inexpensive method to record neural activity in humans. However, it lacks spatial resolution making it difficult to determine which areas of the brain are responsible for the observed EEG response. Here we present a new easy-to-use method that relies on EEG topographical templates. Using MRI and fMRI scans of 50 participants, we simulated how the activity in each visual area appears on the scalp and averaged this signal to produce functionally defined EEG templates. Once created, these templates can be used to estimate how much each visual area contributes to the observed EEG activity. We tested this method on extensive simulations and on real data. The proposed procedure is as good as bespoke individual source localization methods, robust to a wide range of factors, and has several strengths. First, because it does not rely on individual brain scans, it is inexpensive and can be used on any EEG data set, past or present. Second, the results are readily interpretable in terms of functional brain regions and can be compared across neuroimaging techniques. Finally, this method is easy to understand, simple to use and expandable to other brain sources

Assessing direction-specific adaptation using the steady-state visual evoked potential:results from EEG source imaging

Studying directional selectivity using neuroimaging in humans is difficult because the resolution is insufficient to directly access directionally selective activity. Here we used motion adaptation of the steady-state visual evoked potential (SSVEP) and source imaging in the frequency domain to detect brain areas that contain direction-selective cells. This study uses a definitive electrophysiological marker for direction-specific adaptation in the SSVEP to localize cortical areas that are direction selective. It has been shown previously that an oscillating stimulus produces an SSVEP response that is dominated by even harmonics of the stimulus frequency. This pattern of response is consistent with equal population responses to each direction of motion. Prolonged exposure to unidirectional motion induces an asymmetry in the population response that is consistent with adaptation of direction-selective cells. This asymmetry manifests itself in the presence of odd harmonic components after adaptation Critically, the feature that indicates the direction used for adaptation is the phase of the odd-harmonic responses. We recorded this signature of direction selectivity in a group of observers whose retinotopic visual areas had been defined from fMRI mapping. We find direction-specific responses throughout retinotopic cortex, with the largest effect in areas V1 (occipital pole) and V3/V3a (dorsal).</p

On determining the intracranial sources of visual evoked potentials from scalp topography:a reply to Kelly et al. (this issue)

The cruciform model posits that if a Visual Evoked Potential component originates in cortical area V1, then stimuli placed in the upper versus lower visual field will generate responses with opposite polarity at the scalp. In our original paper (Ales et al., 2010b) we showed that the cruciform model provides an insufficient criterion for identifying V1 sources. This conclusion was reached on the basis of simulations that used realistic 3D models of early visual areas to simulate scalp topographies expected for stimuli of different sizes and shapes placed in different field locations. The simulations indicated that stimuli placed in the upper and lower visual field produce polarity inverting scalp topographies for activation of areas V2 and V3, but not for area V1. As a consequence of the non-uniqueness of the polarity inversion criterion, we suggested that past studies using the cruciform model had not adequately excluded contributions from sources outside V1. In their comment on our paper, Kelly et al. (this issue) raise several concerns with this suggestion. They claim that our initial results did not use the proper stimulus locations to constitute a valid test of the cruciform model. Kelly et al., also contend that the cortical source of the initial visually evoked component (C1) can be identified based on latency and polarity criteria derived from intracranial recordings in non-human primates. In our reply we show that simulations using the suggested critical stimulus locations are consistent with our original findings and thus do not change our conclusions regarding the use of the polarity inversion criterion. We further show that the anatomical assumptions underlying the putatively optimal locations are not consistent with available V1 anatomical data. We then address the non-human primate data, describing how differences in stimuli across studies and species confound an effective utilization of the non-human primate data for interpreting human evoked potential responses. We also show that, considered more broadly, the non-human primate literature shows that multiple visual areas onset simultaneously with V1. We suggest several directions for future research that will further clarify how to make the best use of scalp data for inferring cortical sources.</p